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ABSTRACT
Background Interstitial lung abnormalities (ILA) 
occur in around 10% of subjects over 60 years, and are 
associated with a higher rate of all- cause mortality. The 
pathogenic mechanisms are unclear, and the putative 
contribution of alterations in the immune response has 
not been explored. Normal ageing is associated with 
immune deficiencies, including Naïve T- cell decrease 
and greater expression of the proliferative- limiting, 
co- inhibitory receptor killer- cell lectin- like receptor G1 
(KLRG1).
Objective To evaluate the frequency and activation 
state of different T- cell subpopulations in ILA subjects.
Methods Peripheral blood mononuclear cells were 
obtained from 15 individuals with ILA, 21 age- matched 
controls and 28 healthy young subjects. T- cells phenotype 
was characterised by flow cytometry, and proliferation 
and activation by stimulation with anti- CD3/anti- CD28 
or phorbol myristate acetate/ionomycin; KLRG1 isoforms 
were evaluated by western blot and cytokines were 
quantified by ELISA and Multiplex.
Results A significant increase of Naïve CD4+T cells 
together with a decrease of central and effector memory 
CD4+T cells was observed in ILA compared with 
age- matched controls. CD4+T cells from ILA subjects 
exhibited greater basal proliferation, which raised 
after anti- CD3/anti- CD28 stimulation. Additionally, a 
significant increase in the levels of interleukin-6 and 
interferon gamma was observed in isolated CD4+T cells 
and plasma of ILA subjects. They also displayed fewer 
KLRG1+/CD4+T cells with an increase of circulating 
E- cadherin, the ligand of KLRG1+. No changes were 
observed with CD8+T cell subsets.
Conclusion CD4+T cells from ILA subjects are highly 
proliferative and show an excessive functional activity, 
likely related to the loss of KLRG1 expression, which may 
contribute to an inflammatory state and the development 
of ILA.
INTRODUCTION
Lung ageing involves a wide range of structural 
changes that result in progressive loss of respiratory 
function.1 2 In addition, cellular changes associated 
with ageing have been related to the development 
of some chronic degenerative lung diseases.3
Studies have shown that 8 to 10 per cent of 
adults over 60 years develop interstitial lung 
abnormalities (ILA), defined as several specific 
patterns of increased lung density observed on chest 
high- resolution CT (HRCT) scans.4 These abnor-
malities may include ground- glass opacities, retic-
ular abnormalities, diffuse centrilobular nodules, 
traction bronchiectasis or architectural distortion 
involving at least 5% of non- dependent portions of 
the lung.4–6 A growing body of evidence suggests 
that ILA is associated with functional lung decline, 
increased respiratory symptoms and increased risk 
to respiratory- specific mortality.7–9 At present, 
however, the pathogenic mechanisms and the role 
of the immune system in the development and 
progression of ILA are unclear.
Ageing is associated with a variety of modifications 
in the immune system. T cells can be broadly clas-
sified into helper T cells (CD4+T) and cytotoxic T 
cells (CD8+T). CD45 and C- C chemokine receptor 
7 (CCR7) are helpful to identify the maturation 
status of these T cells: Naïve (CCR7+/CD45RA+), 
central memory (TCM, CCR7+/CD45RA-), effector 
memory (TEM, CCR7-/CD45RA-) and effector 
memory RA (TEMRA, CCR7-/CD45RA+).10
During ageing, the accumulation of differentiated 
and less proliferative T cells (TEM and TEMRA) and 
Key messages
What is the key question?
 ► Is there a role of abnormalities in the immune 
system that may contribute to the development 
of ageing- associated interstitial lung 
abnormalities (ILA)?
What is the bottom line?
 ► This study reveals that subjects with ILA 
showed several alterations in the cellular 
immune response, including an increased 
frequency of Naïve CD4+T cells with a decrease 
of the inhibitory KLRG1 expression resulting 
in the presence of highly proliferative and pro- 
inflammatory CD4+T cells.
Why read on?
 ► This is the first study that demonstrates 
a specific association between ILA and 
phenotypic and functional abnormalities of the 
immune system.
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the decrease of Naïve T cells represent features of the immune 
system senescence (immunosenescence).11 High- differentiated 
T cells have decreased expression of co- stimulator molecules 
such as CD27 and CD28, and consequently, their prolifera-
tion and survival capabilities are affected.12 Importantly, the 
expression of the proliferative- limiting, co- inhibitory receptor 
killer- cell lectin like receptor G1 (KLRG1) on T cell surface 
rises with age. KLRG1- transgenic mice have demonstrated that 
antigen- stimulated T cells in the presence of KLRG1’s ligand, 
E- cadherin, inhibits the proliferative capacity of CD8+T cells, 
and similarly, KLRG1- expressing CD4+T cells have affected 
their proliferation capacity.13 14 KLRG1 could be expressed as a 
monomer (M), dimer (D), trimer (T) and tetramer (Tt), and has 
been suggested that the multimerisation of KLRG1 increases the 
avidity to E- cadherin.15
The progressive loss of the immune protection associated with 
ageing might be crucial in the emergence of respiratory disorders 
in older populations. Currently, there are no studies approaching 
specific alterations in the immune system that could contribute 
to the development of ILA. We hypothesised that T cells from 
ILA persons have a different phenotype and modified func-
tions compared with an age- matched normal population. In this 
context, the present study aimed to identify the phenotype of T 
cells in individuals with ILA and evaluate their activation/prolif-
eration activities that may participate in the development of ILA.
METHODS
Detailed methods are provided in the online supplemental file 1.
Study populations
Respiratory asymptomatic volunteers aged 60 or older have been 
invited to participate in our ‘Lung Ageing Programme’. From this 
cohort, 15 individuals with ILA and 21 age- matched controls 
were evaluated. For comparison, we also included 28 healthy 
young subjects. We obtained demographic and pulmonary func-
tion tests data. Two expert thoracic radiologists examined CT 
scans, and ILA was diagnosed by the existence of different struc-
tural alterations including the presence of ground- glass opacities, 
reticular abnormalities, diffuse centrilobular nodules, honey-
combing, traction bronchiectasis, non- emphysematous cysts or 
architectural distortion involving at least 5% of non- dependent 
portions of the lung. CT findings were classified according to the 
recent classification reported by Fleischner Society.16
Preparation of cells
Peripheral blood mononuclear cells (PBMCs) were collected 
via ficoll density gradient (Lymphoprep Axis- Shield, Oslo, 
Norway). The enrichment of total T cells and CD4+T cells was 
performed by negative selection (Miltenyi Biotec, Bergisch Glad-
bach, Germany) as described in the online supplemental file 1.
Western blot
CD4+ and CD4− T cells were lysed, and total proteins were 
subjected to SDS- PAGE under non- reducing conditions. Protein 
bands were detected by incubation with enhanced chemilumi-
nescence reagent (Thermo Scientific, Pierce Biotechnology, 
Rockford, Illinois), and visualised with the Imaging System from 
Bio- Rad (ChemiDoc XRS+System) as described in the online 
supplemental file 1. More information of the used antibodies is 
indicated in online supplemental figure S1.
Multiparametric cytometry analysis
PBMCs were obtained and prepared to flow cytometry anal-
ysis, as described in the online supplemental file 1 and online 
supplemental figure S2. More information of the used antibodies 
is indicated in online supplemental figure S1.
Polyclonal stimulation of T cells
Total T cells enrichment were stimulated with polyclonal stimuli. 
Supernatants were collected for cytokine measurements and cells 
for proliferation assay, as described in the online supplemental 
file 1 and online supplemental figure S3. More information of 
the used antibodies is indicated in online supplemental figure S1.
ELISA determinations in culture supernatants and plasma 
samples
Standard ELISA for the cytokine interferon gamma (IFN-γ), inter-
leukin (IL)-2, IL-6 and IL-10 (Biolegend), and for the proteins 
E- cadherin and granzyme B (R&D Systems) was performed as 
described in the online supplemental file 1.
Multiple cytokine assay in supernatant samples
A Bio- Plex Pro Human cytokine 48- Plex Screening Panel was 
used as described in the online supplemental file 1.
Statistical analysis
Normal distribution was corroborated by the Kolmogorov- 
Smirnov test, and data are reported as mean±SD or frequency 
and percentage according to the type of variable. Clinical data 
were statistically analysed with Student’s t- test or Fisher exact 
tests. The ELISA results were compared among the three groups 
by one- way analysis of variance test and Dunnett as post- hoc 
analysis. Differences in T cell subpopulation and markers 
frequencies by flow cytometry were evaluated by multiple t- tests, 
and a Holm- Sidak was used to adjust for multiple comparisons. 
Additionally, the correlation age/CD4 and CD8 T cell subpop-
ulations were analysed by straight- line regression, slope and 
intercept were calculated and compared between elderly with or 
without ILA. Database, statistics and graphics were made with 
GraphPad Prism 8 (GraphPad Software, USA).
RESULTS
Baseline characteristics of study populations
In this study, we examined 15 subjects with ILA from our Lung 
Ageing Programme, and 21 age- matched controls randomly 
selected from the same cohort but with normal HRCT. We also 
include 28 health younger subjects (age 24±4 years old, 54% 
males). As expected, individuals with ILA were predominantly 
smoker males, and we did not find differences in lung function 
tests (table 1).
According to with the classification proposed by the Fleischner 
Society,16 10 individuals (67%) showed subpleural fibrotic ILA 
and 5 individuals (33%) showed subpleural non- fibrotic ILA 
(figure 1A,B, respectively).
Table 1 Demographic and pulmonary function characteristics
Variable Old n=21 Old+ILA n=15 P value
Age (years) 67±6 70±9 0.2
Gender, male (%) 3 (14) 12 (80) 0.0001
Smoke, former (%) 8 (38) 12 (80) 0.01
FVC (% predicted) 104±33 99.8±13 0.7
FEV1 (% predicted) 103±20 105±20 0.7
DLCO (% predicted) 113±21 105±15 0.2
DLCO, diffusion capacity for carbon monoxide; FEV1, forced expiratory lung volume in the 
first second; FVC, forced vital capacity; ILA, interstitial lung abnormalities.
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The distribution of CD4+T cell subpopulations differs 
between ILA persons and the normal older control group
Maturity status of T cells is relevant to induce specific functions, 
and this status physiologically changes during ageing.12 We anal-
ysed the frequency of CD4+ and CD8+T cells subpopulations 
by flow cytometry, following the analyses strategy indicated in 
online supplemental figure S2.
Inside the gate of the CD4+T cell, we first evaluated the frequency 
of Naïve, TCM, TEM and TEMRA subpopulations (figure 2A). As 
expected, the older control group displayed a decreased frequency of 
Naïve CD4+T cells with an increment of TCM and TEM subpopulations 
compared with the young group, thus presenting the characteristic 
profile of maturity status subpopulations that occurs during ageing.
In contrast, the ILA group did not follow the same pattern, and 
the profile of subpopulations distribution was more similar to the 
younger cohort (figure 2A). Furthermore, in the older control group 
the loss of Naïve and gain of memory cells correlated directly with 
their age, demonstrating that the intercept of their lines were signifi-
cantly different in Naïve, TCM and TEM CD4+T cells compared with 
the ILA group (figure 2B).
Figure 1 CT scan in two different respiratory asymptomatic subject of our cohort. Panel A: Subpleural non- fibrotic ILA. Panel B: Subpleural fibrotic 
ILA. ILA,interstitial lung abnormalities.
Figure 2 Frequency of naïve and memory CD4+T cells are altered in persons with interstitial lung abnormalities (ILA) compared with old control 
group. Peripheral mononuclear cells were prepared to flow cytometry. First, live cells were identified, and the gate of CD3+CD4+ or CD3+CD8+T 
cells was delimited. Then, CCR7 and CD45RA expression were evaluated to obtain the frequency of: Naïve (CD45RA+CCR7+), central Memory (CM, 
CD45RA- CCR7+), effector Memory (EM, CD45RA- CCR7-) and TEMRA (CD45RA+CCR7-) in CD4+ or CD8+T cells subpopulations (panel A and C, 
respectively). Panel B: Individual variations in their rate of change of CD4+T cells subpopulations over age; graphic shows the individual- behaviour 
of each individual, and the regression line per group- age (line colour per group is indicated). Panel D: Individuals vary in their rate of change of 
CD8+T cells subpopulations over age; graphic shows the individual- behaviour of each individual and the regression line per group- age (line colour 
per group is indicated). Graphs show individual values, mean±SD (young: n=12, old: n=13, old+ILA: n=10). *p<0.05 **p<0.01 ***p<0.0001. 
Statistical analysis was performed with multiple t- tests and a Holm- Sidak method was used to adjustment for multiple comparisons; asterisks 
indicate comparison of the three groups. When the asterisk is on a line, indicates, the comparison between old control group and old +ILA. CCR7,C- C 
chemokine receptor 7; TCM, central memory; TEM, effector memory; TEMRA, effector memory RA.
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Inside CD8+T cells, results showed a classic distribution of 
Naïve, TCM, TEM and TEMRA during the ageing, characterised 
by the decrease in the frequency of Naïve and increase of TCM, 
TEM and TEMRA without differences between the older control 
group and ILA cohort (figure 2C). Likewise, CD8+T subsets not 
correlated with age in both old groups independently of the ILA 
presence (figure 2D).
CD4+T cells from ILA person loss the high expression of 
KLRG1 characteristic of ageing
Next, we evaluated by flow cytometry the expression of markers 
to differentiate between cellular senescence or exhaustion status. 
The loss of CD27 and CD28, as well as the high expression of 
CD57 or KLRG1, is a phenotype associated to cellular senes-
cence, whereas high expression of programmed cell death 1 
(PD-1) is associated to exhaustion status.17
Thus, CD27, CD28, CD57, KLRG1 and PD-1 expression 
were evaluated inside CD4+ and CD8+T cells gates using 
PBMC as described in online supplemental figure S2. Our 
results showed that ILA subjects had decreased frequency of 
KLRG1+CD4+T cells compared with the older control group, 
while the expression of the other molecules was not affected 
(figure 3A). Interestingly, KLRG1 was also decreased in the 
intensity of expression as compared with the older control group 
(figure 3B). Also, CD4+T cells from ILA persons have increased 
intensity of CD27 expression.
KLRG1 is an inhibitory receptor on T cells, and it has been 
suggested that the multimerisation of KLRG1 increases the 
avidity to its ligand E- cadherin, and consequently enhance the 
sensitivity to induce the inhibitory activity on T cells.15 We puri-
fied CD4+and CD4− T cells from our study groups to eval-
uate the KLRG1 isoforms by western blot (figure 3C). Our data 
suggest that CD4+T cells from ILA persons have predominantly 
the Tt isoform with loss of the M isoform, probably as a compen-
satory mechanism to the low frequency of KLRG1+CD4+T 
cells (figure 3D).
Contrary, CD8+T cells from ILA persons display a similar 
profile of senescence and exhaustion status than the older control 
group. As is illustrated in online supplemental figure S4A,B, 
CD8+T cells phenotype in both groups were characterised by 
the decrease of frequency and mean fluorescence intensity of 
CD27 and CD28, and the increase of CD57. KLRG1 expression 
was not affected, and isoforms were not detected by western blot 
(online supplemental figure S4C).
CD4+T cells from ILA are highly proliferative
In order to clarify the activation status of CD4+T cells from ILA 
persons, we purified T cells and stimulated them with anti- CD3/
anti- CD28 or phorbol myristate acetate (PMA)/ionomycin to 
verify their activation and proliferation ability. Results of T- cells 
from the younger group were considered as a reference value, 
normalised to 100%.
CD25 expression was evaluated by flow cytometry as indica-
tive of activation status. We were not able to identify a statistical 
difference in the expression of this marker. However, the older 
control group had 50% more frequency of CD25+CD4+T 
Figure 3 CD4+T cells from subjects with interstitial lung abnormalities (ILA) loss the KLRG1 expression compared with old control group. Peripheral 
mononuclear cells were prepared to flow cytometry and western blot. First, live cells were identified, the gate of CD3+CD4+was delimited, and 
then the expression of CD27, CD28, CD57, KLRG1 and PD1 was evaluated by percentage and mean fluorescence intensity (MFI) (panels A and B, 
respectively). Panel C: Total T cells were obtained using a Pan T kit and then CD4+T cells were enriched. The expression of KLRG1 was evaluated in 
the fraction of CD4+T cells by western blot under non- reducing condition. Panel D: Band densities were normalised against GAPDH by densitometry 
analysis and results are shown in relative units of concentration using IMAGEJ software; bars show mean±SD. In panels A and B, graphs show 
individual value mean±SD from: Young: n=12, old: n=13, old+ILA: n=10. Western blot was performed in two subjects per group. *p<0.05 **p<0.01. 
Statistical analysis was performed with multiple t- tests and a Holm- Sidak method was used to adjustment for multiple comparisons; asterisks 
indicate comparison of the three groups. When the asterisk is on a line, indicates, the comparison between old control group and old+ILA. CCR7,C- C 
chemokine receptor 7; KLRG1, killer- cell lectin- like receptor G1; PD-1, programmed cell death 1.
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cells than the young group, and this profile was maintained at 
basal conditions and after any of the stimulation conditions 
(figure 4A). By contrast, under basal conditions, the frequency 
of CD25+CD4+T cells in the ILA group was similar to the 
younger group and also increased under stimulation (figure 4A). 
Importantly, in comparison with the older controls, CD4+T 
cells from ILA group, exhibited a significantly higher prolifer-
ative background from the basal condition that was maintained 
under both stimulation conditions (figure 4B).
Finally, we measured the levels of IL-2 in culture supernatant 
as an indirect marker of activation and proliferation status. As 
we expected, CD4+T cells from the old control cohort increased 
the IL-2 level in response to anti- CD3/anti- CD28 stimuli, but 
under the same condition, ILA group released near double levels 
of IL-2 (figure 4C). However, under PMA/ionomycin stimuli 
both old controls and ILA subjects produced high and similar 
levels of IL-2 (figure 4C). Therefore, CD4+T cells from ILA 
are highly activated under specific anti- CD3/anti- CD28 stimulus 
where KLRG1 should inhibit it, but not when treated with PMA/
ionomycin because this stimulus induces activation down- stream 
of KLRG1 inhibition. Together, these data suggest that CD4+T 
cells from ILA group are more sensitive to activation and prolif-
eration likely associated with the loss of KLRG1 expression.
Regarding activation and proliferation status of CD8+T 
cells, we did not observe differences between older control and 
ILA groups (online supplemental figure S5A,B). However, a 
decreased level of granzyme B under both stimulation conditions 
was observed in culture supernatants from the ILA group (online 
supplemental figure S5C).
CD4+T cells from ILA subjects secrete a different cytokine 
profile compared with age-matched normal controls
CD4+T cells mediate the immune response through the secre-
tion of specific cytokines; a simplified form to divide the 
function of the cytokine families is according their effects as pro- 
inflammatory and anti- inflammatory subsets, although in recent 
years, subsets with more specialised and defined properties were 
described.18
Because CD4+T cells from ILA group have loss KLRG1 
expression and they have a high background of proliferation and 
activation, we performed a wide screening of cytokines/chemo-
kines released in the culture supernatants to clarify whether 
CD4+T cells from ILA group has a specific profile. From a panel 
of 48 molecules, we observed a different profile between older 
control and ILA groups in the release of 10 cytokines, 3 growth- 
factors and 1 chemokine (figure 5).
From them, IL-6 and IFN-γ levels were increased at the basal 
condition in ILA’s CD4+T cells, but in response to the stim-
ulus, both study groups produced similar amounts of these 
cytokines (figure 5A). These results demonstrated by the first 
time that T cells from ILA group are continually delivering 
high levels of IL-6 and IFN-γ. Interestingly, the increase of the 
different cytokine/chemokine levels was dependent of the stim-
ulus received; IL1-β and IL-8 were increased after both anti- 
CD3/CD28 and PMA/IO (figure 5B, up- line), suggesting that 
the synthesis of IL-1β and IL-8 could be induced independently 
of the alteration in the KLRG1 pathway. However, IL-18 and 
the chemokine CXCL10 were increased specifically under anti- 
CD3/CD28 stimuli (figure 5B, middle- line), whereas IL-15, 
G- CSF and VEGF levels were increased only under PMA/IO 
stimuli (figure 5B, low- line). T cells from ILA group deliv-
ered lower lymphotoxin levels than the older control group 
under both anti- CD3/CD28 and PMA/IO stimulus, but IL-17 
and macrophage colony- stimulating factor (M- CSF) levels 
were decreased only under anti- CD3/CD28 stimuli (figure 5C, 
up- line) while the tumor necrosis factor (TNF) and IL- 12p70 
levels were decreased only under PMA/IO stimuli (figure 5C, 
low- line).
The other analysed proteins did not show differences (online 
supplemental figure S6). Some proteins levels were out of the 
limit detection; for example, IL-2 and MIP- 1a levels were up 
limit whereas IL-5 was down limit (data not shown).
Figure 4 CD4 +T cells from persons with interstitial lung abnormalities (ILA) display high proliferative capacity compared with old control group. 
Enriched T cells were cultured 48 hours with polyclonal stimuli using either monoclonal antibodies anti- CD3 and CD28 (both at 1 µg/mL) or phorbol 
myristate acetate (PMA) 50 nM/ionomycin (IO) 2 ng/µL, culture medium (Media) and isotype control (I.C) to monoclonal antibodies were used as 
negative controls. Cells were recovered and prepared to flow cytometry and culture supernatants were used to determine interleukin (IL)-2 by ELISA. 
By flow cytometry, CD3+CD4+cells were delimited and the expression of CD25 (for activation) and Ki-67 (for proliferation) were evaluated (panel A 
and B, respectively); the level of activation and proliferation displayed for CD4+T cells from young group was considered as 100% (black dot line). 
Panel C: IL-2 released by stimulated T cells was measured by ELISA in the culture’ supernatants. Graphs show individual value mean±SD (n=5 per 
group). *p<0.05 **p<0.01. Statistical analysis was performed with one- way analysis of variance test and Dunnett as post hoc analysis (ELISA data), 
and multiple t- tests with a Holm- Sidak to adjustment for multiple comparisons (flow cytometry data). Asterisks indicate comparison of the three 
groups. When the asterisk is on a line, indicates, the comparison between old control group and old+ILA. M- CSF, macrophage colony- stimulating 
factor; TNF, tumor necrosis factor.
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Figure 5 Under polyclonal stimuli the T cells from persons with interstitial lung abnormalities (ILA) secrete a specific pro- inflammatory profile. 
Enriched T cells were cultured 48 hours with polyclonal stimuli either with monoclonal antibodies anti- CD3 and CD28 (both at 1 µg/mL) or phorbol 
myristate acetate (PMA) 50 nM/ionomycin (IO) 2 ng/µL; culture medium (Media) and isotype control (I.C) to monoclonal antibodies were used as 
negative controls. Culture supernatant was used to evaluate several molecules by Multiplex. We observed diverse behaviour in the profile of delivered 
pro- inflammatory cytokines; a first cytokine group was spontaneously release (stimuli- independent), a second group showed increased level and a 
third group showed decreased level in response to polyclonal stimuli (panel A, B and C, respectively). Graphs show individual value mean±SD (n=5 
per group). *p<0.05 **p<0.01 ***p<0.001 compared old versus old+ILA, statistical analysis was performed with one- way analysis of variance tests 
and adjusted by the Holm- Sidak method for multiple comparisons. IFN-γ,interferon gamma; IL, interleukin.
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Together, our data suggest that T cells from ILA persons 
are able to secrete a specific pro- inflammatory profile, char-
acterised by high production of cytokines such as IFN-γ, IL-6, 
IL-1β, IL-8 and IL-18. Nevertheless, interestingly, despite this 
pro- inflammatory profile, they produce lower classical pro- 
inflammatory cytokines such as TNF or lymphotoxin.
Concentrations of IFN-γ and IL-6 are increased in plasma from 
ILA subjects
Since we found in vitro that T cells from ILA group induced 
a pro- inflammatory cytokine profile, we hypothesised that ILA 
persons might have high levels of some pro- inflammatory cyto-
kines in the blood. In order to confirm our hypothesis, we used 
an ELISA assay and measured the plasma levels of IFN-γ and 
IL-6 as pro- inflammatory cytokines as well as IL-10 as an anti- 
inflammatory cytokine.
Our data showed that ILA subjects have significantly higher 
levels of IFN-γ and IL-6 compared with both the younger and 
older control groups (figure 6A,B, respectively), whereas, IL-10 
level did not show differences between groups (figure 6C). In 
addition, the levels of soluble E- cadherin were increased in both 
older controls and ILA group compared with the young cohort 
(figure 6D). Interestingly, soluble granzyme B, an effector mole-
cule produced by CD8+T cells, was decreased in plasma from 
ILA group compared with older control cohort (figure 6E), paral-
leling our findings when CD8+T cells were stimulated in vitro 
(online supplemental figure S5C). Together, these results suggest 
that ILA subjects have a systemic pro- inflammatory profile likely 
associated with the activation of CD4+T cells, and that probably 
the cytotoxic function of CD8+is affected.
DISCUSSION
Interstitial lung abnormalities are observed in a small but signif-
icant percentage of older, mostly smoker individuals. Longitu-
dinal follow- up studies have demonstrated that ILA persists in 
about 60% of affected individuals and more important, that 
progress in 20% to 40% within 6 years and is associated with a 
higher risk of all- cause mortality.7 9 19
It is well known that with age there is a progressive decline 
in the capacity of mounting a robust T cells response, among 
other reasons, by the loss of Naïve T cells and accumulation 
of memory T cells.11 12 Our findings indicate that ILA persons 
exhibit a different immunological profile compared to normal 
old individuals with similar demographic characteristics and that 
these differences affect primarily CD4+T cells both in pheno-
type and function.
ILA group displayed an imbalance in CD4+T cells subpopu-
lations, characterised by an increase in the frequency of Naïve 
T cells, and a decrease of memory subsets. Probably the high 
frequency of naïve CD4+T cells is favouring the recognising of 
a vast repertory of potential new antigens. Additionally, CD4+T 
cells subpopulations from ILA subjects compared with the old 
control group showed higher intensity of CD27 expression, and 
they did not gain the expression of the proliferative- limiting, 
co- inhibitory receptor KLRG1, which characteristically occurs 
in the normal ageing process (figure 7). Moreover, our data 
showed that these cells had increased proliferative and func-
tional activities at least in part associated with the decreased 
frequency of KLRG1+CD4+T cells.
Even if CD4+T cells from ILA expressed the Tt form of 
KLRG1, perhaps as a compensatory mechanism to its low 
Figure 6 Individuals with interstitial lung abnormalities (ILA) display 
high levels of pro- inflammatory cytokines in plasma. Plasma was 
obtained and prepared to measure several soluble proteins by ELISA. 
Plasma concentrations of IFN-γ, IL-6, IL-10, E- cadherin and granzyme 
B were evaluated (panel A, B, C, D and E, respectively). Graphs show 
individual value mean±SD (young: n=16, old: n=15, old+ILA: n=11). 
*p<0.05 **p<0.01. Statistical analysis was performed with an one- way 
analysis of variance test adjusted by the Dunnett method; asterisks 
indicate comparison of the three groups. When the asterisk is on a line, 
indicates, the comparison between old control group and old+ILA. IFN-
γ,interferon gamma; IL, interleukin.
Figure 7 Summary of main differences in the phenotype of CD4+T 
cells comparing young- old- old/interstitial lung abnormalities (ILA). The 
decrease of the frequency of naïve and the increase of memory CD4+T 
cells, as well as the loss of the co- stimulatory molecule CD27 and the 
gain of the ‘brake molecule’ KLRG1 is considered a normal process 
in ageing, as illustrated when compare young versus old persons. By 
contrast, our data showed that old/ILA does not show this typical 
phenotype profile, when compared with old controls; actually, old/ILA is 
characterised by increased frequency of naïve and decreased frequency 
of memory CD4+T cells, and these cells do not lose the expression of 
CD27 and do not express KLRG1. KLRG1, killer- cell lectin- like receptor 
G1; MFI, mean fluorescence intensity; PD-1, programmed cell death 1; 
TCM,central memory; TEM, effector memory; TEMRA, effector memory RA.
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expression, this was not enough to avoid that CD4+T cells from 
ILA group were highly proliferative. Typically, KLRG1 exerts 
its inhibitory effects through one ITIM motif contained in its 
cytoplasmic domain and recruiting SHIP-1 and SHIP-2 phos-
phatases, which negatively regulate the function of PI3K. This 
pathway inhibits the activation of the serine- threonine kinase 
Akt affecting the activation of several kinases, transcription 
factors and other regulatory molecules.20 (figure 8A).
The loss of KLRG1 expression on CD4+T cell from ILA is 
perpetuating an unspecific activation, as demonstrated by our data 
which show that even without stimuli these cells present twofold 
proliferation compared with CD4+T cells from older control 
group which, as expected, displayed increased KLRG1 expression 
and low proliferation compared with younger group (figure 8B).
Additionally, CD4+T cells from ILA group release a character-
istic pro- inflammatory profile, either spontaneously or after stim-
ulation. In culture, these cells delivered spontaneously high levels 
of IL-6 and IFN-γ, which resulted also increased at the systemic 
level (in plasma). These findings suggest that IL-6 and IFN-γ could 
be biomarkers for early identification of ILA, which is relevant 
because currently, the identification of this disorder rests only on 
HRCT.
Our results are in concordance with observations in other 
models, where the lack of KLRG1 expression on T- cells conferred 
them a functional competitive advantage, because the KLRG1 
ligation decreases the TCR signalling, inhibiting the proliferative 
capacity and decreasing cytokine production.21 22 We hypothe-
sised that the high production of cytokines, like IL-6 and IFN-γ, 
and proliferative ability of CD4+T cells in ILA subjects might 
be independent of their differentiation status (naïve vs memory). 
However, probably it is a result of the lack of KLRG1 expres-
sion, which is a ‘brake- molecule’.
Moreover, under polyclonal stimuli, CD4+T cells from 
ILA persons released significant amounts of a variety of pro- 
inflammatory cytokines, mainly those related to the inflam-
masome such as IL-1β, IL-8 and IL-18. IL-1β and IL-18 are 
members of the IL-1 family and are critical mediators of 
inflammation in several pathologies, including infectious and 
autoimmune disorders.23 Signalling through IL-18 induces tran-
scription and secretion of a subset of pro- inflammatory mole-
cules, including IFN-γ by CD4+T cells as we observed in our 
study.24 Whereas IL-8, is a chemokine essential for neutrophil- 
mediated inflammation and angiogenesis.
Curiously, also under polyclonal stimuli, CD4+T cells from 
ILA persons, compared with older, lost their ability to produce 
the classical pro- inflammatory cytokines such as TNF and 
IL-17. This profile was similar to younger controls, suggesting 
that both ILA and young groups still conserve other pathways 
to control an excessive secretion of specific cytokines like TNF 
and IL-17.
Together, these data indicate that the deregulated cytokine/
chemokine profile displayed by CD4+T cells from ILA persons 
may contribute to a higher systemic pro- inflammatory status and 
the development of the interstitial pulmonary abnormalities.
In sharp contrast, no differences between the ILA and the 
older control groups were observed in the distribution of CD8+ 
subpopulations, as well as in the expression of immunosenes-
cence markers and the proliferative capacity. However, both 
systemic and in vitro levels of granzyme B were decreased in ILA 
persons. Probably, its decreased expression may be a compen-
satory anti- apoptotic mechanism since, for example, reduced 
granzyme B expression in different mouse models is associated 
with improved wound healing and less inflammation and fibrosis 
compared with control mice.25
Figure 8 Schematic summary of the consequences of lack of KLRG1 expression on CD4+T cells from old+ILA patients. Panel A: KLRG1 is over- 
expressed on CD4+T cells in old subjects. After KLRG1 ligation, its inhibitory effect occurs through the recruitment of SHIP-1 and SHIP-2 phosphatases, 
which negatively regulate the function of PI3K and consequently the serine- threonine kinase Akt is inhibited, as well as the TCR signalling. Panel 
B: CD4+T cells from ILA are deficient in KLRG1 expression and consequently the inhibitory signalling is not activated. Then, CD4+T cells display an 
enhanced activation status and a pro- inflammatory functional profile, which is characterised by the high production of cytokines like IL-6 and IFN-γ. 
IFN-γ, interferon gamma; IL, interleukin; ILA, interstitial lung abnormalities; KLRG1, killer- cell lectin- like receptor G1.
159Machahua C, et al. Thorax 2021;76:152–160. doi:10.1136/thoraxjnl-2020-215520
 on F













Our results of CD8+T cells in ILA open several questions; we 
did not clarify if the function of these cells is affected. Unfor-
tunately, studies on phenotype and function of CD8+T cells 
in ageing and immunosenescence are limited,26 27 and further 
research is necessary to identify the contribution of CD8+T cells 
in the development of ILA.
Our study has limitations, such as the small sample size and 
the heterogeneity of the individuals with ILA included in the 
study (subpleural fibrotic and subpleural non- fibrotic). However, 
our findings are consistent to indicate, by the first time, that 
CD4+T- lymphocytes from ILA subjects display high proliferative 
activity, likely related to the loss of KLRG1 expression, and a pro- 
inflammatory profile, which may contribute to the development 
of ILA.
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